BI’s Article search uses Boolean search capabilities. If you are not familiar with these principles, here are some quick tips.
To search specifically for more than one word, put the search term in quotation marks. For example, “workers compensation”. This will limit your search to that combination of words.
To search for a combination of terms, use quotations and the & symbol. For example, “hurricane” & “loss”.
(Reuters) — Bayer AG on Tuesday said a hearing by a U.S. judge on a $2 billion deal to resolve future legal claims that its widely used weedkiller Roundup causes cancer has been postponed by one week until May 19, following previous delays.
Speaking at the German crop chemicals and seeds group’s annual shareholder meeting, Chief Executive Werner Baumann said he was optimistic about the hearing to be chaired by judge Vince Chhabria, which would determine further proceedings. A final hearing would be held at yet a later stage, he added.
Bayer on Feb. 3 came to terms with plaintiffs’ lawyers in a $2 billion pledge to resolve future claims, as the products in question, based on the glyphosate herbicide, will remain on the market.
Bayer, which stressed that leading global regulators have found Roundup to be safe, agreed in principle last year to settle U.S. claims that have already been lodged for up to $10.9 billion.
(Reuters) — Attorneys for Bayer AG and consumers suing the company over allegations its Roundup weedkiller caused cancer told a judge on Thursday they are continuing to resolve thousands more cases, improving prospects for its $11 billion deal to end the litigation.